propranolol has been researched along with Minimal Disease, Residual in 3 studies
Propranolol: A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs.
propranolol : A propanolamine that is propan-2-ol substituted by a propan-2-ylamino group at position 1 and a naphthalen-1-yloxy group at position 3.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Tennakoon, G | 1 |
| Auer, R | 1 |
| Yang, K | 1 |
| Feng, L | 1 |
| Chen, S | 1 |
| Ji, Y | 1 |
| Yu, Z | 1 |
| Cai, R | 1 |
| Chang, L | 1 |
| Qiu, Y | 1 |
| Chen, X | 1 |
| Chen, Q | 1 |
| Ma, G | 1 |
| Jin, Y | 1 |
| Lin, X | 1 |
3 other studies available for propranolol and Minimal Disease, Residual
| Article | Year |
|---|---|
"Don't let it to air": A cautionary tale of the potential consequences of surgery of residual cancer.
Topics: Adrenergic beta-Antagonists; Animals; Cyclooxygenase 2 Inhibitors; Etodolac; Mice; Neoplasm, Residua | 2023 |
Progressive infantile hepatic hemangioma not responding to propranolol.
Topics: Adrenergic beta-Antagonists; Age of Onset; Child, Preschool; Disease Progression; Fatal Outcome; Fem | 2019 |
Clinical and radiological outcomes of infantile hemangioma treated with oral propranolol: A long-term follow-up study.
Topics: Administration, Oral; Child, Preschool; Disease Progression; Erythema; Female; Follow-Up Studies; He | 2019 |